Svas Med Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
as on 15-11-2024
- Paid Up Capital ₹ 2.08 Cr
as on 15-11-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 15-11-2024
- Satisfied Charges ₹ 7.42 Cr
as on 15-11-2024
- Revenue 25.02%
(FY 2023)
- Profit 43.80%
(FY 2023)
- Ebitda 449.17%
(FY 2023)
- Net Worth -24.40%
(FY 2023)
- Total Assets -18.48%
(FY 2023)
About Svas Med
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 2.08 Cr.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹7.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kumar Agarwal, Ritesh Pandey, and Vishal Bali serve as directors at the Company.
- CIN/LLPIN
U85100DL2010PTC205726
- Company No.
205726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Svas Med?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Agarwal  | Director | 26-Feb-2021 | Current |
Ritesh Pandey  | Director | 14-May-2021 | Current |
| Vishal Bali | Director | 26-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Svas Med.
Svas Med Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.02% increase. The company also saw a substantial improvement in profitability, with a 43.8% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svas Med?
In 2023, Svas Med had a promoter holding of 83.50% and a public holding of 16.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rhea Healthcare Private LimitedActive 16 years 7 monthsRitesh Pandey and Vishal Bali are mutual person
Origin International Fertility Centre Private LimitedActive 17 years 6 monthsKumar Agarwal is a mutual person
Asian Institute Of Nephrology And Urology (Chennai) Private LimitedActive 7 years 3 monthsVishal Bali is a mutual person
- Asian Institute Of Nephrology And Urology Private LimitedActive 13 years 6 months
Vishal Bali is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Jul 2022 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Mar 2020 | ₹5.00 M | Satisfied |
Hdfc Bank Limited Creation Date: 30 Jan 2020 | ₹5.00 M | Satisfied |
How Many Employees Work at Svas Med?
Svas Med has a workforce of 37 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svas Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svas Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
